드러그인포 약품요약정보

허가정보

항목

내용

청구코드(KD코드)
비급여점검코드
상한금액

[A30650821] [보험코드에 따른 약품기본정보 직접조회]
\0 원/1g(2006.11.01)(현재약가)
\158 원/1g(2004.09.01)(변경전약가)
[상병코드조회]
[질병코드조회]

빠른조회


요약정보	[효능] [용법] [금기] [신중투여] [이상반응]

상세정보	[효능] [용법] [경고] [금기] [신중투여] [이상반응] [일반주의] [상호작용] [임산부] [수유부] [소아] [고령자] [신장애환자] [간장애환자] [적용주의] [과량투여] [임상검사치] [보관] [기타]

제품성상

백색의 연고제 [제형정보 확인]

효능효과

[적응증 별 검색]

다음 경우의 일시적 완화 : 치열, 치핵, 가려움, 부종, 출혈, 짓무름

용법용량

* 절대 임의복용하지 마시고 반드시 의사 또는 약사와 상담하시기 바랍니다.

[처방약어]
[주성분코드:459600COM 에 따른 심사지침열람]
15세 이상 : 1일 1 ∼ 3회, 1회 1g을 환부에 직접 바른다. 항문내에 적용시 주입기를 사용하여 항문내에 짜 넣는다

[BMI지수 계산] [Body Surface Area 계산] [Cockcroft-Gault GFR 계산] [MDRD GFR 계산]

주요약물 상호작용

[조회]

금기

1) 환부가 화농되어 있는 환자
2) 심질환, 고혈압, 갑상선 질환, 당뇨병, 전립선 비대증으로 인한 배뇨곤란 환자

신중투여

1) 이 약 사용에 의해 발적, 부종, 자극감, 화농 등의 증상이 나타날 경우
2) 이 약 사용에 의해 알레르기 증상(발진, 발적, 가려움 등)이 나타날 경우
3) 7일 정도 사용하여도 증상의 개선이 나타나지 않을 경우
4) 출혈이 있는 경우

Related FDA Approved Drug

기준 성분:HYDROCORTISONE
ACETASOL HC (ACETIC ACID, GLACIAL; HYDROCORTISONE)
ACETIC ACID W/ HYDROCORTISONE (ACETIC ACID, GLACIAL; HYDROCORTISONE)
ACHROMYCIN (HYDROCORTISONE; TETRACYCLINE HYDROCHLORIDE)
ACTICORT (HYDROCORTISONE)
ACYCLOVIR AND HYDROCORTISONE (ACYCLOVIR; HYDROCORTISONE)
AEROSEB-HC (HYDROCORTISONE)
A-HYDROCORT (HYDROCORTISONE SODIUM SUCCINATE)
ALA-CORT (HYDROCORTISONE)
ALA-SCALP (HYDROCORTISONE)
ALPHADERM (HYDROCORTISONE; UREA)
ANUSOL HC (HYDROCORTISONE)
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE (BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
BALNEOL-HC (HYDROCORTISONE)
BETA-HC (HYDROCORTISONE)
CALMURID HC (HYDROCORTISONE; UREA)
CARMOL HC (HYDROCORTISONE ACETATE; UREA)
CETACORT (HYDROCORTISONE)
CHLOROMYCETIN HYDROCORTISONE (CHLORAMPHENICOL; HYDROCORTISONE ACETATE)
CIPRO HC (CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE)
COLOCORT (HYDROCORTISONE)
COLY-MYCIN S (COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE)
COR-OTICIN (HYDROCORTISONE ACETATE; NEOMYCIN SULFATE)
CORT-DOME (HYDROCORTISONE)
CORTEF (HYDROCORTISONE)
CORTEF ACETATE (HYDROCORTISONE ACETATE)
CORTENEMA (HYDROCORTISONE)
CORTIFOAM (HYDROCORTISONE ACETATE)
CORTISPORIN (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
CORTRIL (HYDROCORTISONE)
DERMACORT (HYDROCORTISONE)
DRICORT (HYDROCORTISONE ACETATE)
ELDECORT (HYDROCORTISONE)
EPICORT (HYDROCORTISONE)
EPIFOAM (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE)
FLEXICORT (HYDROCORTISONE)
GLYCORT (HYDROCORTISONE)
HC #1 (HYDROCORTISONE)
HC #4 (HYDROCORTISONE)
HC (HYDROCORTISONE) (HYDROCORTISONE)
H-CORT (HYDROCORTISONE)
HEMSOL-HC (HYDROCORTISONE ACETATE)
HI-COR (HYDROCORTISONE)
HYDROCORTISONE (HYDROCORTISONE)
HYDROCORTISONE ACETATE (HYDROCORTISONE ACETATE)
HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1% (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE)
HYDROCORTISONE AND ACETIC ACID (ACETIC ACID, GLACIAL; HYDROCORTISONE)
HYDROCORTISONE BUTYRATE (HYDROCORTISONE BUTYRATE)
HYDROCORTISONE IN ABSORBASE (HYDROCORTISONE)
HYDROCORTISONE SODIUM PHOSPHATE (HYDROCORTISONE SODIUM PHOSPHATE)
HYDROCORTISONE SODIUM SUCCINATE (HYDROCORTISONE SODIUM SUCCINATE)
HYDROCORTISONE VALERATE (HYDROCORTISONE VALERATE)
HYDROCORTONE (HYDROCORTISONE)
HYDRO-RX (HYDROCORTISONE)
HYTONE (HYDROCORTISONE)
LOCOID (HYDROCORTISONE BUTYRATE)
LOCOID LIPOCREAM (HYDROCORTISONE BUTYRATE)
MICORT-HC (HYDROCORTISONE ACETATE)
NEO-CORT-DOME (ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE)
NEO-CORTEF (HYDROCORTISONE ACETATE; NEOMYCIN SULFATE)
NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
NOGENIC HC (HYDROCORTISONE)
NUTRACORT (HYDROCORTISONE)
OPHTHOCORT (CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE)
ORABASE HCA (HYDROCORTISONE ACETATE)
ORLEX HC (ACETIC ACID, GLACIAL; HYDROCORTISONE)
OTICAIR (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
OTOBIONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
OTOBIOTIC (HYDROCORTISONE; POLYMYXIN B SULFATE)
OTOCORT (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
PANDEL (HYDROCORTISONE PROBUTATE)
PEDIOTIC (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
PENECORT (HYDROCORTISONE)
PRAMOSONE (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE)
PROCTOCORT (HYDROCORTISONE)
PROCTOFOAM HC (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE)
PYOCIDIN (HYDROCORTISONE; POLYMYXIN B SULFATE)
SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE)
STIE-CORT (HYDROCORTISONE)
SYNACORT (HYDROCORTISONE)
TERRA-CORTRIL (HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE)
TEXACORT (HYDROCORTISONE)
U-CORT (HYDROCORTISONE ACETATE; UREA)
VOSOL HC (ACETIC ACID, GLACIAL; HYDROCORTISONE)
WESTCORT (HYDROCORTISONE VALERATE)
ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
기준 성분:DIPHENHYDRAMINE HYDROCHLORIDE
ADVIL PM (DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN)
AMBENYL (BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE)
AMBODRYL (BROMODIPHENHYDRAMINE HYDROCHLORIDE)
ANTITUSSIVE (DIPHENHYDRAMINE HYDROCHLORIDE)
BELDIN (DIPHENHYDRAMINE HYDROCHLORIDE)
BELIX (DIPHENHYDRAMINE HYDROCHLORIDE)
BENADRYL (DIPHENHYDRAMINE HYDROCHLORIDE)
BENADRYL PRESERVATIVE FREE (DIPHENHYDRAMINE HYDROCHLORIDE)
BENYLIN (DIPHENHYDRAMINE HYDROCHLORIDE)
BROMANYL (BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE)
BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE (BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE)
DIBENIL (DIPHENHYDRAMINE HYDROCHLORIDE)
DIPHEN (DIPHENHYDRAMINE HYDROCHLORIDE)
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE (DIPHENHYDRAMINE HYDROCHLORIDE)
HYDRAMINE (DIPHENHYDRAMINE HYDROCHLORIDE)
SILPHEN (DIPHENHYDRAMINE HYDROCHLORIDE)
VICKS FORMULA 44 (DIPHENHYDRAMINE HYDROCHLORIDE)
기준 성분:DIBUCAINE HYDROCHLORIDE
HEAVY SOLUTION NUPERCAINE (DIBUCAINE HYDROCHLORIDE)
기준 성분:CHLORHEXIDINE HYDROCHLORIDE
기준 성분:ALLANTOIN

정보요약

드럭인포 의약품 요약/상세정보

코드 및 분류정보

항목	내용
BIT 약효분류	혈관강화제, 정맥류 치료제, 치질약(Capillary stabilizer, Phlebitis, Varicose veins, Hemorrhoidal)
ATC 코드	AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE / C05A [코드분류상세설명] [ATC코드예측]
복지부분류코드	256 (치질용제 )
주성분코드 분석 및 중복처방 검토	[주성분코드 분석 및 중복처방 검토]
Drugs By Indication	[전체보기]
Drugs By Classification	[전체보기]

제품정보

항목	내용
청구코드(KD코드) 비급여점검코드 상한금액	[A30650821] [보험코드에 따른 약품기본정보 직접조회] \0 원/1g(2006.11.01)(최신약가) \158 원/1g(2004.09.01)(변경전약가) [상병코드조회] [질병코드집 다운로드]
제품성상	백색의 연고제 [제형정보 확인]

복약정보

항목

내용

LACTmed 바로가기

[바로가기]

약리작용

유료정보입니다.

복약지도

유료정보입니다.

임부에대한투여

*	전체임신 기간별로 여러등급이 존재할 수 있으며 가장 위험도가 높은 정보만 보여집니다. 단, 복합제의 경우 모든 복합제성분에 대한 임부투여등급이 표시된것은 절대 아니며 표시된것중에 가장 위험도가 높은 정보만 나타납니다.

FDA : C등급

*	상기 임부투여에 대한 정보는 전산처리 되면서 입력 오류 가능성이 존재합니다. 오류 가능성을 최소화하기 위하여 많은 노력을 기울이고 있으나, 그 정확성에 대하여 확신을 드릴 수 없습니다. 이에 대해 회사는 책임을 지지 않습니다.
*	반드시 공신력 있는 문헌을 다시 한번 참고 하시기 바라며 의사 또는 약사의 판단에 따라 투여여부가 결정되어야 합니다.

Pharmacokinetics

유료정보입니다.

병용금기 및 연령대금기 근거조회

[병용금기 및 연령대금기 근거조회]

제형별 복약지도

[연고]

보관상 주의

조제시 주의

심사정보

항목	내용
DUR 관련 고시	[병용연령금기 의약품 / 임부금기 의약품 / 비용효과적 함량 의약품 / 안전성 관련 급여중지 의약품]

학술정보

항목	내용
DUR (의약품사용평가)	병용금기 : 고시된 병용금기 내용은 없습니다. [상호작용/병용금기검색] 연령대금기 : 고시된 연령금기 내용은 없습니다. [연령대금기상세검색]
독성정보	Diphenhydramine에 대한 독성정보 : 정보보기 L-Menthol에 대한 독성정보 : 정보보기 출처: 국립독성과학원 독성물질정보DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do
Mechanism of Action	Chlorhexidine에 대한 Mechanism_Of_Action 정보 Chlorhexidine's antimicrobial effects are associated with the attractions between chlorhexidine (cation) and negatively charged bacterial cells. After chlorhexidine is absorpted onto the organism's cell wall, it disrupts the integrity of the cell membrane and causes the leakage of intracellular components of the organisms. Dibucaine에 대한 Mechanism_Of_Action 정보 Local anesthetics block both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions. This reversibly stabilizes the membrane and inhibits depolarization, resulting in the failure of a propagated action potential and subsequent conduction blockade. Diphenhydramine에 대한 Mechanism_Of_Action 정보 Diphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. Hydrocortisone에 대한 Mechanism_Of_Action 정보 Hydrocortisone binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In another words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Phenylephrine에 대한 Mechanism_Of_Action 정보 Phenylephrine produces its ophthalmic and systemic actions by acting on alpha 1 adrenergic receptors in the pupillary dilator muscle and the vascular smooth musle, resulting in contraction of the dilator muscle and contraction of the smooth muscle in the arterioles of the conjunctiva and peripheral vasoconstriction. Phenylephrine decreases nasal congestion by acting on alpha 1 adrenergic receptors in the arterioles of the nasal mucosa to produce constriction.
Pharmacology	Chlorhexidine에 대한 Pharmacology 정보 Chlorhexidine, a topical antimicrobial agent, is bactericidal. Because of its positive charge, the chlorhexidine molecule reacts with the microbial cell surface to destroy the integrity of the cell membrane. This novel mechanism of action makes it highly unlikely for the development of bacterial resistance. Dibucaine에 대한 Pharmacology 정보 Dibucaine is an amide-type local anesthetic, similar to lidocaine. Diphenhydramine에 대한 Pharmacology 정보 Diphenhydramine is an antihistamine of the ethanolamine class. Ethanolamine antihistamines have significant antimuscarinic activity and produce marked sedation in most patients. In addition to the usual allergic symptoms, the drug also treats irritant cough and nausea, vomiting, and vertigo associated with motion sickness. It also is used commonly to treat drug-induced extrapyramidal symptoms as well as to treat mild cases of Parkinson's disease. Rather than preventing the release of histamine, as do cromolyn and nedocromil, diphenhydramine competes with free histamine for binding at HA-receptor sites. Diphenhydramine competitively antagonizes the effects of histamine on HA-receptors in the GI tract, uterus, large blood vessels, and bronchial muscle. Ethanolamine derivatives have greater anticholinergic activity than do other antihistamines, which probably accounts for the antidyskinetic action of diphenhydramine. This anticholinergic action appears to be due to a central antimuscarinic effect, which also may be responsible for its antiemetic effects, although the exact mechanism is unknown. Hydrocortisone에 대한 Pharmacology 정보 Hydrocortisone is the most important human glucocorticoid. It is essential for life and regulates or supports a variety of important cardiovascular, metabolic, immunologic and homeostatic functions. Topical hydrocortisone is used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids and sex steroids by having different receptors, target cells, and effects. Technically, the term corticosteroid refers to both glucocorticoids and mineralocorticoids, but is often used as a synonym for glucocorticoid. Glucocorticoids suppress cell-mediated immunity. They act by inhibiting genes that code for the cytokines IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and TNF-alpha, the most important of which is the IL-2. Reduced cytokine production limits T cell proliferation. Glucocorticoids also suppress humoral immunity, causing B cells to express lower amounts of IL-2 and IL-2 receptors. This diminishes both B cell clonal expansion and antibody synthesis. The diminished amounts of IL-2 also leads to fewer T lymphocyte cells being activated. Phenylephrine에 대한 Pharmacology 정보 Phenylephrine is a powerful vasoconstrictor. It is used as a mydriatic, nasal decongestant, and cardiotonic agent. Phenylephrine is a postsynaptic alpha-receptor stimulant with little effect on the beta receptors of the heart. Parenteral administration of Phenylephrine causes a rise in systolic and diastolic pressures, cardiac output is slightly decreased and peripheral resistance is considerably increased, most vascular beds are constricted; renal, splanchnic, cutaneous, and limb blood flows are reduced but coronary blood flow is increased. Pulmonary vessels are constricted, and pulmonary arterial pressure is raised. This alpha receptor sympathetic agonist is also used locally because its vasoconstrictor and mydriatic action.
Protein Binding	Chlorhexidine에 대한 단백결합 정보 87% Dibucaine에 대한 단백결합 정보 Not Available Diphenhydramine에 대한 단백결합 정보 98 to 99% Hydrocortisone에 대한 단백결합 정보 95% Phenylephrine에 대한 단백결합 정보 95% binding-plasma proteins
Half-life	Chlorhexidine에 대한 반감기 정보 Not Available Dibucaine에 대한 반감기 정보 Not Available Diphenhydramine에 대한 반감기 정보 1-4 hours Hydrocortisone에 대한 반감기 정보 6-8 hours Phenylephrine에 대한 반감기 정보 2.1 to 3.4 hours
Absorption	Chlorhexidine에 대한 Absorption 정보 Absorption of chlorhexidine from the gastrointestinal tract is very poor. Additionally, an in vivo study in 18 adult patients found no detectable plasma or urine chlorhexidine concentrations following insertion of four periodontal implants under clinical conditions. Dibucaine에 대한 Absorption 정보 In general, ionized forms (salts) of local anesthetics are not readily absorbed through intact skin. However, both nonionized (bases) and ionized forms of local anesthetics are readily absorbed through traumatized or abraded skin into the systemic circulation. Diphenhydramine에 대한 Absorption 정보 Quickly absorbed with maximum activity occurring in approximately one hour. Hydrocortisone에 대한 Absorption 정보 Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Phenylephrine에 대한 Absorption 정보 Reduced bioavailability (compared to pseudoephedrine) following oral administration due to significant first-pass metabolism.
Pharmacokinetics	L-menthol의 약물동력학자료 소실 : 흡수된 약물은 glucuronide 포합체로서 소변 및 담즙을 통해 배설된다. Phenylephrine HCl의 약물동력학자료 효과발현시간 근육주사, 피하주사 : 10~15분 이내 정맥주사 : 즉시 효과지속시간 근육주사 : 30분 ~ 2시간 정맥주사 : 15~30분 피하주사 : 1시간 대사 : Phenolic 포합체로 대사됨. Monoamine oxidase에 의해 간과 장에서 대사됨. 반감기 : 2.5 시간 소실 : 신배설 (90%) Tocopherol Acetate의 약물동력학자료 흡수 : 경구 : 소장으로부터 흡수되는 데에는 담즙이 필요하다. 흡수 저하 : 흡수장애 환자, 저체중 미숙아, 고용량 투여 유화제제보다 수용성 제제가 더 잘 흡수된다. 분포 : 모든 조직에 분포하며, 특히 지방조직에 고농도로 분포하고 저장된다. 대사 : 간에서 glucuronides 포합 소실 : 주로 담즙을 통해 (70-80%) 배설된다. Dibucaine HCl의 약물동력학자료 작용발현시간 : 15분 이내 작용지속시간 : 2-4 시간 흡수 : 손상되지 않은 피부에 적용시 흡수는 매우 적지만, 점막이나 손상된 피부로부터는 잘 흡수된다. Diphenhydramine HCl의 약물동력학자료 최고 진정 효과 : 1-3 시간 작용지속시간 : 4-7 시간 흡수 : 초회통과효과가 있어서 40 - 60 % 정도가 전신순환으로 들어감 대사 : 대부분 간대사, 일부는 폐와 신장에서도 대사 단백결합 : 78% 최고혈중농도 도달시간 : 2-4 시간 Hydrocortisone acetate의 약물동력학자료 흡수 : 직장을 제외한 모든 투여경로에서 빠르게 흡수된다. 대사 : 간에서 대사된다. 생리적 반감기 : 8∼12시간 소실 : 주로 17-hydroxysteroids와 17-ketosteroids의 형태로 신배설된다. 용해성이 큰 다른 약물과 비교했을 때 hydrocortisone acetate는 작용발현시간은 느리지만 작용지속시간이 길다. Hydrocortisone sodium succinate는 물에 쉽게 녹아 빨리 활성화된다.
Biotransformation	Dibucaine에 대한 Biotransformation 정보 Primarily hepatic. Diphenhydramine에 대한 Biotransformation 정보 Hepatic and renal Hydrocortisone에 대한 Biotransformation 정보 Primarily hepatic via CYP3A4 Phenylephrine에 대한 Biotransformation 정보 Oral phenylephrine is extensively metabolised by monoamine oxidase, an enzyme which is present in the stomach and liver.
Toxicity	Chlorhexidine에 대한 Toxicity 정보 LD₅₀= 2g/kg (human, oral); LD₅₀= 3 g/kg (rat, oral); LD₅₀= 2.5 g/kg (mice, oral); LD₅₀= 21 mg/kg (male rat, IV); LD₅₀= 23 mg/kg (female rat, IV); LD₅₀= 25 mg/kg (male mice, IV); LD₅₀= 24 mg/kg (female mice, IV); LD₅₀= 1g/kg (rat, subcutaneous); LD₅₀= 637 mg/kg (male mice, subcutaneous); LD₅₀= 632 mg/kg (female mice, subcutaneous) Dibucaine에 대한 Toxicity 정보 Subcutaneous LD₅₀ in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest. Diphenhydramine에 대한 Toxicity 정보 LD₅₀=500 mg/kg (orally in rats). Considerable overdosage can lead to myocardial infarction (heart attack), serious ventricular dysrhythmias, coma and death. Hydrocortisone에 대한 Toxicity 정보 Side effects include inhibition of bone formation, suppression of calcium absorption and delayed wound healing Phenylephrine에 대한 Toxicity 정보 Not Available
Drug Interactions	Chlorhexidine에 대한 Drug_Interactions 정보 Not Available Dibucaine에 대한 Drug_Interactions 정보 Methotrexate The NSAID increases the effect and toxicity of methotrexateLithium The NSAID increases serum levels of lithiumAcenocoumarol The NSAID increases the anticoagulant effect Diphenhydramine에 대한 Drug_Interactions 정보 Atomoxetine The CYP2D6 inhibitor could increases the effect and toxicity of atomoxetineDonepezil Possible antagonism of actionGalantamine Possible antagonism of actionMesoridazine Increased risk of cardiotoxicity and arrhythmiasRivastigmine Possible antagonism of actionThioridazine Increased risk of cardiotoxicity and arrhythmias Hydrocortisone에 대한 Drug_Interactions 정보 Ambenonium The corticosteroid decreases the effect of anticholinesterasesEdrophonium The corticosteroid decreases the effect of anticholinesterasesNeostigmine The corticosteroid decreases the effect of anticholinesterasesPyridostigmine The corticosteroid decreases the effect of anticholinesterasesAspirin The corticosteroid decreases the effect of salicylatesBismuth Subsalicylate The corticosteroid decreases the effect of salicylatesSalicylate-magnesium The corticosteroid decreases the effect of salicylatesSalicylate-sodium The corticosteroid decreases the effect of salicylatesSalsalate The corticosteroid decreases the effect of salicylatesTrisalicylate-choline The corticosteroid decreases the effect of salicylatesWarfarin The corticosteroid alters the anticoagulant effectAcenocoumarol The corticosteroid alters the anticoagulant effectDicumarol The corticosteroid alters the anticoagulant effectAnisindione The corticosteroid alters the anticoagulant effectCholestyramine Cholestyramine decreases the effect of hydrocortisoneColestipol Cholestyramine decreases the effect of hydrocortisoneAmobarbital The barbiturate decreases the effect of the corticosteroidAprobarbital The barbiturate decreases the effect of the corticosteroidButabarbital The barbiturate decreases the effect of the corticosteroidButalbital The barbiturate decreases the effect of the corticosteroidButethal The barbiturate decreases the effect of the corticosteroidDihydroquinidine barbiturate The barbiturate decreases the effect of the corticosteroidHeptabarbital The barbiturate decreases the effect of the corticosteroidHexobarbital The barbiturate decreases the effect of the corticosteroidMethohexital The barbiturate decreases the effect of the corticosteroidMethylphenobarbital The barbiturate decreases the effect of the corticosteroidPentobarbital The barbiturate decreases the effect of the corticosteroidPhenobarbital The barbiturate decreases the effect of the corticosteroidPrimidone The barbiturate decreases the effect of the corticosteroidQuinidine barbiturate The barbiturate decreases the effect of the corticosteroidSecobarbital The barbiturate decreases the effect of the corticosteroidTalbutal The barbiturate decreases the effect of the corticosteroidRifampin The enzyme inducer decreases the effect of the corticosteroidPhenytoin The enzyme inducer decreases the effect of the corticosteroidMephenytoin The enzyme inducer decreases the effect of the corticosteroidFosphenytoin The enzyme inducer decreases the effect of the corticosteroidEthotoin The enzyme inducer decreases the effect of the corticosteroidMidodrine Increased arterial pressure Phenylephrine에 대한 Drug_Interactions 정보 Alseroxylon Increased arterial pressureIsocarboxazid Increased arterial pressureDeserpidine Increased arterial pressureGuanethidine The agent decreases the effect of guanethidineRasagiline Increased arterial pressureMethyldopa Increased arterial pressureMidodrine Increased arterial pressurePargyline Increased arterial pressurePhenelzine Increased arterial pressureReserpine Increased arterial pressureTranylcypromine Increased arterial pressureOxytocin Possible marked increase of arterial pressureMethylergonovine Possible marked increase of arterial pressureLinezolid Possible increase of arterial pressureErgonovine Possible marked increase of arterial pressureTrimipramine The tricyclic increases the sympathomimetic effectProtriptyline The tricyclic increases the sympathomimetic effectNortriptyline The tricyclic increases the sympathomimetic effectClomipramine The tricyclic increases the sympathomimetic effectAmitriptyline The tricyclic increases the sympathomimetic effectAmoxapine The tricyclic increases the sympathomimetic effectDesipramine The tricyclic increases the sympathomimetic effectDoxepin The tricyclic increases the sympathomimetic effectImipramine The tricyclic increases the sympathomimetic effectMoclobemide Moclobemide increases the sympathomimetic effect
CYP450 Drug Interaction	[CYP450 Table직접조회]
Drug Target	[Drug Target]
Description	Chlorhexidine에 대한 Description 정보 A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. [PubChem] Dibucaine에 대한 Description 정보 A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006) Diphenhydramine에 대한 Description 정보 A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. Hydrocortisone에 대한 Description 정보 The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. [PubChem] Phenylephrine에 대한 Description 정보 An alpha-adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. [PubChem]
Dosage Form	Chlorhexidine에 대한 Dosage_Form 정보 Aerosol TopicalDressing TopicalGel TopicalKit DentalLiquid BuccalLiquid OralLiquid TopicalLotion TopicalOintment TopicalSolution TopicalSponge Topical Dibucaine에 대한 Dosage_Form 정보 Ointment Rectal Diphenhydramine에 대한 Dosage_Form 정보 Capsule OralCream TopicalElixir OralLiquid IntramuscularLiquid IntravenousLiquid OralLozenge OralStrip OralSyrup OralTablet OralTablet, chewable Oral Hydrocortisone에 대한 Dosage_Form 정보 Aerosol RectalCream TopicalEnema RectalLiquid TopicalLotion TopicalOintment OphthalmicOintment TopicalPowder, for solution IntramuscularPowder, for solution IntravenousTablet Oral Phenylephrine에 대한 Dosage_Form 정보 Liquid IntramuscularLiquid IntravenousLiquid OphthalmicOintment TopicalSolution IntravenousSolution / drops OphthalmicStrip OralTablet Oral
Drug Category	Chlorhexidine에 대한 Drug_Category 정보 Anti-Bacterial AgentsAnti-Infective Agents, LocalAnti-InfectivesDisinfectantsMouthwashes Dibucaine에 대한 Drug_Category 정보 Anesthetics, Local Diphenhydramine에 대한 Drug_Category 정보 AnestheticsAnesthetics, LocalAnti-Allergic AgentsAntidyskineticsAntiemeticsAntiparkinson AgentsAntipruriticsAntitussivesEthanolamine DerivativesHistamine H1 AntagonistsHypnotics and Sedatives Hydrocortisone에 대한 Drug_Category 정보 Anti-inflammatory Agents Phenylephrine에 대한 Drug_Category 정보 Adrenergic alpha-AgonistsCardiotonic AgentsMydriaticsNasal DecongestantsSympathomimeticsVasoconstrictor Agents
Smiles String Canonical	Chlorhexidine에 대한 Smiles_String_canonical 정보 NC(NC1=CC=C(Cl)C=C1)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 Dibucaine에 대한 Smiles_String_canonical 정보 CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC Diphenhydramine에 대한 Smiles_String_canonical 정보 CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1 Hydrocortisone에 대한 Smiles_String_canonical 정보 CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C21 Phenylephrine에 대한 Smiles_String_canonical 정보 CNCC(O)C1=CC(O)=CC=C1
Smiles String Isomeric	Chlorhexidine에 대한 Smiles_String_isomeric 정보 N\C(NC1=CC=C(Cl)C=C1)=N/C(N)=N/CCCCCC\N=C(N)\N=C(/N)NC1=CC=C(Cl)C=C1 Dibucaine에 대한 Smiles_String_isomeric 정보 CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC Diphenhydramine에 대한 Smiles_String_isomeric 정보 CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1 Hydrocortisone에 대한 Smiles_String_isomeric 정보 C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@H]21 Phenylephrine에 대한 Smiles_String_isomeric 정보 CNC[C@H](O)C1=CC(O)=CC=C1
InChI Identifier	Chlorhexidine에 대한 InChI_Identifier 정보 InChI=1/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34)/f/h31-32H,25-28H2/b29-19+,30-20+,33-21+,34-22+ Dibucaine에 대한 InChI_Identifier 정보 InChI=1/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)/f/h21H Diphenhydramine에 대한 InChI_Identifier 정보 InChI=1/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 Hydrocortisone에 대한 InChI_Identifier 정보 InChI=1/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 Phenylephrine에 대한 InChI_Identifier 정보 InChI=1/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1
Chemical IUPAC Name	Chlorhexidine에 대한 Chemical_IUPAC_Name 정보 (1E)-2-[6-[[amino-[[amino-[(4-chlorophenyl)amino]methylidene]amino]methylidene]amino]hexyl]-1-[amino-[(4-chlorophenyl)amino]methylidene]guanidine Dibucaine에 대한 Chemical_IUPAC_Name 정보 2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide Diphenhydramine에 대한 Chemical_IUPAC_Name 정보 2-[di(phenyl)methoxy]-N,N-dimethylethanamine Hydrocortisone에 대한 Chemical_IUPAC_Name 정보 (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one Phenylephrine에 대한 Chemical_IUPAC_Name 정보 3-[(1R)-1-hydroxy-2-methylaminoethyl]phenol
Drug-Induced Toxicity Related Proteins	HYDROCORTISONE 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:Interleukin-8 Drug:hydrocortisone Toxicity:inflammation. [바로가기]

사용자컨텐츠

항목

내용

핵심 요약 정보